Team
Rapid Pharma Development Team
Dr. Robert Hett
Managing Partner
Email: robert.hett@rpd-ch.com
Mobile CH: +41 79 471 9502
Mobile D: +49 1761 471 9502
Education:
Chemist RWTH-Aachen
Postdoc University of Notre Dame, USA
Key experience:
Business Development, Process Chemistry, API Development, GMP, CRO Management, CMC Project Management, Audits, Patents, Publications, Board member of OPRD
Previous Experience:
Carbogen: Site Manager, of a pilot plant of 80 people, API custom manufacturing for early phase development under c-GMP
Sepracor:
Senior Research Chemist
Dr. Dieter Krimmer
Managing Partner
Email: dieter.krimmer@rpd-ch.com
Mobile CH: +41 76 328 3337
Mobile D: +49 1761 328 3337
Education:
Chemist, TH Stuttgart
Key experience:
Project Management, Fermentation, Chemical and Formulation Development, Drug Product, Regulatory Experience (FDA, EMEA, Bfarm), Validation, Qualification, Audits and Inspections
Previous Experience:
Independent Consultant:
CMC Management for e.g. Gilead, Trigen
Hofmann La Roche:
Technical Team Leader for the products INVIRASE®, VIRACEPT®, TAMIFLU®
Dr. Jens Schlegel
Associate Partner
Mail: jens.schlegel@rpd-ch.com
Mobile CH : +41 78 712 4053
Education:
Chemist, University Ulm
Economy, Graduate School of Business Administration (GSBA) Zurich
Key experience:
Drug Substance and medicinal product development, scale up, validation and commercialization, Analytical Method validation, CMC Project Management, CDMO auditing and supplier qualifications, RA, QP and QA.
Previous Experience:
Phoenixus AG: Head CMC Global
Tillotts Pharma AG: Head Technical Alliance
RohnerChem AG: Head Chemical Development
Siegfried AG: Head Chemical Development
SynphaBase AG: Marketing Manager
Carbogen AG: Senior Chemist
Freelance Partners
Patrick Page, PhD, MBA
Freelance Consultant for RPD
Decode Pharma Partners
3 Cours Charlemagne
69002 Lyon, France
Mobile : +33 6 46 80 05 59
Email: patrick.page@decodepharma-partners.com
Homepage: www.decodepharma-partners.com
Education:
PhD, Biochemistry, Medicinal Chemistry, Uni. of Toulouse;
MBA, Management in Healthcare, INSEEC Paris
Key experience:
Experienced drug developer and biotech entrepreneur. Founder and co-founder of 3 Biotech companies (Genkyotex on French stock market, Epiremed, Conicmeds). Full-time and part-time executive positions (CEO, CSO, CDO/COO) in several early stage biotech companies. Appointed permanent scientific advisor for the Biopark of Brussels South Charleroi (Wallonia region, BE). 22+ years in pharmaceutical industry: Strategic Project Management, Leadership and Execution, Target Validation, Drug Discovery, Medicinal Chemistry, Preclinical Research and Development, ADME/DMPK/Tox. Filed >25 patents, designed IP and in-licensing strategy, and led patent portfolio for several companies. Inventor and key contributor for Nolasiban, OBE-022, Setanaxib. Major contribution in the birth, business plan, business and R&D strategy, discovery and development plan, and fund raising of several biotechs/spin-off either as executive/non-executive member or acting as a freelance consultant (Genkyotex, Epiremed, Epics Therapeutics, Conicmeds, Gepeceron,…). Multiple due diligence for VC firms, Business angels, TTO and research institutions.
Selected Previous Experience:
Conicmeds SAS (FR):
CEO, Director of Preclinical Development and CMC. Membrane nanospacers targeting pulmonary obstructive diseases
Epiremed SAS (FR):
CSO, Director of Drug Discovery. Compounds targeting epigenetic enzymes for cancers
Genkyotex SA (CH):
Senior Research Advisor. R&D process; Metabolic and Ophtalmological programmes.
Serono Pharma (CH) :
Senior Project Director preclinical development; GPCR, Kinases, Ions channels modulators for several therapeutic indications
Astrazeneca (SE) :
Project Director drug discovery programmes; Discovery research on several programmes
Dr. Olaf Mundszinger
Freelance Consultant for RPD
A&O Pharmadienstleistungen
Am Sattel 17
D 79588 Efringen-Kirchen
Germany
Phone: +49 7628 950 3119
Mobile: +49 170 275 0459
Email: o.mundszinger@aopharma.de
Homepage: www.aopharma.de
Education:
Chemist University of Freiburg and Saarland
Study of Pharmaceutical Sciences, QP
Key experience:
Qualified Person, GMP, Audits, Pharmaceutical Quality System, Quality Control, Quality Assurance, Validation, IMPD Writing
Previous Experience:
Develco Pharma: Head QC, Managing director QA, QP
CU Chemie Uetikon: API manufacturing development, QC
Dr. Timo Schmidt
Freelance Consultant for RPD
Managing Director
Talisto GmbH
Neuhofstrasse 18
CH - 8834 Schindellegi
Switzerland
Phone: +41 44 542 11 20
Mobile: +41 79 969 05 38
Email: t.schmidt@talisto.ch
Homepage: www.talisto.ch
Education:
Pharmacist, Universities Würzburg and Munich, Germany
Ph.D. University of Basel, Switzerland
Executive MBA, Instituto de Empresa, Spain
Key experience:
Product Development from concept to technology transfer including regulatory processes, Product Strategy and Life Cycle Management, IP Management, Licensing- and Business Development, RP/QP/fvP services (Switzerland), CDMO and CMC Project Management, Start-Up support (food, pharma, cosmetics).
Previous Experience:
EffRx:
Chief Scientific Officer, Member of the management board; overseeing R&D, Regulatory Affairs, Drug Safety, Intellectual Property, Technical Operation and Quality Management. Bone diseases, oncology supportive care, metabolic disease (PCOS)
IDC:
Co-founder, CEO and board member; building a product development and CMC service company from scratch (formulation development, analytical services, technology transfer). Various product classes.
Aenova:
Director Corporate R&D; global R&D and product development strategy and -services management for Temmler Group (4 R&D sites, 1 built out), business development, client consulting.
Mepha:
Various roles with increasing responsibilities from sourcing of APIs to international tech transfer and product development.
Dr. Goran Westerberg, Ph. D.
Freelance Consultant for RPD
La Crocina Pharmaceutical Consultants Lp
Email: goran.westerberg@crocina.com
Education:
PhD Radiopharmacology, University of Uppsala, Sweden
Key experience:
>30 years in pharmaceutical industry: Clinical and Regulatory Development, Early (Phase I-IIb) clinical studies, Preclinical Development, Due Diligence evaluations, Project Management. Experience from >600 clinical trials, including 36 FTIH studies.
Previous Experience:
Siena Biotech SpA:
Director, Clinical & Regulatory Development. Neuroscience and Oncology programs.
Pfizer/Pharmacia Inc:
Director, Clinical Pharmacokinetics. CNS-, Urology-, Oncology and Cardiovascular programs.
Pharmacia & Upjohn:
Senior Research Advisor. R&D process; Clinical and Regulatory Management.
Uppsala PET Centre:
Associate Director; Clinical Pharmacology studies.
